Ticker Symbol: ENVB
Enveric Biosciences Inc
$1.78 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0000890821
Company Profile
Enveric Biosciences is a patient-first biotechnology company developing rigorously tested, novel cannabinoid medicines to improve quality of life for cancer patients. Initial indications include radiodermatitis, a common and often severe side effect of radiation therapy, and chemotherapy-induced neuropathy.
Sector: Manufacturing
Industry: Semiconductor and Related Device Manufacturing
Standard Industrial Classification Code (SIC code): 3674
Address: 5000 Research Ct Ste 750
Website: www.enveric.com
CEO: Brent Kelton
Tags:
N/A
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $2.70
Change:
$0.45
(
20.00%)
Days Range: $2.18 - $2.75
Beta: 1.76
52wk. High: $6.98
52wk. Low: $1.30
Ytd. Change 28.17%
50 Day Moving Average: $2.23
200 Day Moving Average: $2.57
Shares Outstanding: 2181912
Valuation
Market Cap: 589.1M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A